(Neavitt, Md. – November 21, 2023) Pancreatic cancer is a relatively rare cancer, representing
only 3 percent of estimated new cancer diagnoses each year. However, it is especially lethal –
presently the 3rd leading cause of cancer death, pancreatic cancer kills more than 50,000
Americans every year.
For the Mid-Shore Pancreatic Cancer Foundation, Inc., supporting efforts to advance the
diagnosis and treatment of pancreatic cancer, and educating the public about risk factors and
symptoms of the disease are key strategies for saving lives. On this year’s World Pancreatic
Cancer Awareness Day (November 16), the Foundation sponsored a seminar, “New Trends in
Pancreatic Cancer Diagnosis and Treatment,” in the Cadby Theatre at Chesapeake College in
Wye Mills, Md.
Designed for clinicians involved in patient care, the evening program featured presentations by
three leading University of Maryland Medical System oncology specialists: Nader Hanna, MD,
Professor of Surgery, UM School of Medicine (UM SOM) and Director of Clinical Operations,
Division of General & Oncologic Surgery, University of Maryland Medical Center (UMMC); Yixing
Jiang, MD, PhD, Professor of Medicine, UM SOM and Director of GI Medical Oncology, Marlene
and Stewart Greenebaum Cancer Center, UMMC; and Jason K. Molitoris, MD, PhD, Associate
Professor of Radiation Oncology, UM SOM, Associate Medical Director, Department of Radiation
Oncology, UMMC, and Director, Clinical Hyperthermia Program.
Dr. Hanna provided an overview of various risk factors for pancreatic cancer, including heredity
(indicating a family history of certain genetic mutations) and smoking, and noted that symptoms
of the disease, such as weight loss, back pain, jaundice and adult-onset (over age 65) diabetes
most often don’t present until the disease is relatively advanced. He also reviewed various
diagnostic strategies and surgical approaches, stressing the importance of surgical resection as
the most significant factor for survival.
Dr. Jiang discussed the genetic aspects of pancreatic cancer and how chemotherapy drugs are
tailored to address the specific mutations identified in individual patients. She noted that
systemic chemotherapy provides curative results for less than 30 percent of patients, and that
side effects can be very severe; however, in many cases it does improve survival time and also
palliates cancer-related symptoms.
Dr. Molitoris described the role of radiation in treating pancreatic cancer, including challenges
caused by the location of the pancreas near other tissues that can be damaged by radiation. He

described the criteria for cases in which radiation is employed prior to surgery to shrink tumor
size, or after surgery to palliate complications from the disease and improve quality of life.
“We were really pleased to have a good turnout for this event, and the presenters provided very
clear and detailed updates from the standpoint of their practice,” said Bill Shrieves, president of
the Mid-Shore Pancreatic Foundation, Inc. “The Foundation does a lot to support pancreatic
cancer patients and to raise funds for research on the disease, but as one of our volunteers
commented, this event might be the most important thing we’ve done as an organization. If just
one of the clinicians who attended does something different based on the information that was
shared and it improves the outcome for a pancreatic cancer patient, that is the best kind of
success.”
Shrieves also credited support from Tidewater Rotary in making the event possible. “A generous
grant of $5,000 from Rotary’s Flags for Cancer Program made it possible for us to offer this
event free of charge, and we are very grateful for that support,” he said.
Established in 2013 The Mid-Shore Pancreatic Cancer Foundation, Inc., sponsors and
participates in events that raise awareness about pancreatic cancer in the community, and also
helps patients and their families in the Mid-Shore region find assistance, financial support, and
transportation to and from treatments. The group also funds research through direct grants or
support for other organizations, such as the Pancreatic Cancer Action Network.
For more information about The Mid-Shore Pancreatic Cancer Foundation, Inc., visit
https://www.midshorepancan.org/ or call 410-745-9243.